These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 31634203)
21. A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs. Schranz AJ Clin Infect Dis; 2020 Jul; 71(3):572-573. PubMed ID: 31504337 [No Abstract] [Full Text] [Related]
22. Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US. Stahler GJ; Mennis J; Baron DA Drug Alcohol Depend; 2021 Sep; 226():108849. PubMed ID: 34198132 [TBL] [Abstract][Full Text] [Related]
23. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs. Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165 [TBL] [Abstract][Full Text] [Related]
24. Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections. Fanucchi LC; Walsh SL; Thornton AC; Nuzzo PA; Lofwall MR Clin Infect Dis; 2020 Mar; 70(6):1226-1229. PubMed ID: 31342057 [TBL] [Abstract][Full Text] [Related]
25. Drug and Alcohol Dependence response to KK-21-1460 "Considering rationales for use in defining subgroups for the treatment of stimulant use disorder". Chan B; Freeman M; Ayers C; Korthuis P; Paynter R; Kondo K; Kansagara D Drug Alcohol Depend; 2021 Apr; 221():108571. PubMed ID: 33597113 [No Abstract] [Full Text] [Related]
26. Hepatitis C and Stimulant Use Disorder: Challenges and Opportunities. Bach P; Ti L Clin Infect Dis; 2020 Dec; 71(11):3009. PubMed ID: 32161955 [No Abstract] [Full Text] [Related]
27. Initiating Opioid Agonist Treatment for Opioid Use Disorder in the Inpatient Setting: A Teachable Moment. Raheemullah A; Lembke A JAMA Intern Med; 2019 Mar; 179(3):427-428. PubMed ID: 30640372 [No Abstract] [Full Text] [Related]
28. Aortic Valve Surgery Outcomes Reporting and Implications for Persons Who Use Drugs With Infectious Endocarditis. Springer SA Clin Infect Dis; 2020 Jul; 71(3):488-490. PubMed ID: 31588502 [No Abstract] [Full Text] [Related]
29. Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs. Chandra DK; Altice FL; Copenhaver MM; Zhou X; Didomizio E; Shrestha R Subst Use Misuse; 2021; 56(7):979-987. PubMed ID: 33769199 [No Abstract] [Full Text] [Related]
30. The opiate-dependent patient with endocarditis: addressing pain and substance abuse withdrawal. Broyles LM; Korniewicz DM AACN Clin Issues; 2002 Aug; 13(3):431-51. PubMed ID: 12151996 [TBL] [Abstract][Full Text] [Related]
31. Is South Africa being spared the global opioid crisis? A review of trends in drug treatment demand for heroin, nyaope and codeine-related medicines in South Africa (2012-2017). Harker N; Lucas WC; Laubscher R; Dada S; Myers B; Parry CD Int J Drug Policy; 2020 Sep; 83():102839. PubMed ID: 32650228 [TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes and health care costs among people entering a safer opioid supply program in Ontario. Gomes T; Kolla G; McCormack D; Sereda A; Kitchen S; Antoniou T CMAJ; 2022 Sep; 194(36):E1233-E1242. PubMed ID: 36122919 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of Clinical Outcomes of Intravenous Drug Use-Related Infective Endocarditis in Buprenorphine-Treated Patients. O'Kane C; Piechowski K; Hoff A; Fang W; Mallow Z; Marshalak P; Burwell S J Pharm Pharm Sci; 2022; 25():266-273. PubMed ID: 36054929 [TBL] [Abstract][Full Text] [Related]
34. Putting Parity into Practice - Integrating Opioid-Use Disorder Treatment into the Hospital Setting. Fanucchi L; Lofwall MR N Engl J Med; 2016 Sep; 375(9):811-3. PubMed ID: 27579631 [No Abstract] [Full Text] [Related]
35. Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder. Schiff DM; Nielsen TC; Hoeppner BB; Terplan M; Hadland SE; Bernson D; Greenfield SF; Bernstein J; Bharel M; Reddy J; Taveras EM; Kelly JF; Wilens TE Am J Obstet Gynecol; 2021 Oct; 225(4):424.e1-424.e12. PubMed ID: 33845029 [TBL] [Abstract][Full Text] [Related]
36. People With Injection Drug Use-associated Endocarditis Deserve More Than Half a Chance at Surgery. Lennox R; Cvetkovic A; O'Shea T Ann Thorac Surg; 2022 Jan; 113(1):373. PubMed ID: 33705781 [No Abstract] [Full Text] [Related]
37. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients. Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493 [TBL] [Abstract][Full Text] [Related]
38. Infective Endocarditis Among Persons Aged 18-64 Years Living with Human Immunodeficiency Virus, Hepatitis C Infection, or Opioid Use Disorder, United States, 2007-2017. Wong CY; Zhu W; Aurigemma GP; Furukawa N; Teshale EH; Huang YA; Peters PJ; Hoover KW Clin Infect Dis; 2021 May; 72(10):1767-1781. PubMed ID: 32270861 [TBL] [Abstract][Full Text] [Related]
39. Variants of opioid genes and response to treatment of opioid use disorder with buprenorphine-naloxone versus extended-release naltrexone in Caucasians. Randesi M; Rotrosen J; Nunes EV; Lee JD; Novo P; Levran O; Ott J; Pavlicova M; Scodes J; Kreek MJ Am J Drug Alcohol Abuse; 2020 Nov; 46(6):761-768. PubMed ID: 32851876 [No Abstract] [Full Text] [Related]
40. People With Injection Drug Use-Associated Endocarditis. An KR; Tam DY; Yanagawa B Ann Thorac Surg; 2022 Jan; 113(1):373-374. PubMed ID: 33798489 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]